Elektroimportøren AS (OSL:ELIMP)
Norway · Delayed Price · Currency is NOK 16.00
-0.05 (-0.31%)
Aug 1, 2025, 4:25 PM CET
Orchard Therapeutics Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 44.6 | 41.6 | -11.79 | 52.07 | 97.24 | 79.91 | Upgrade |
Depreciation & Amortization | 103.01 | 102.01 | 95.29 | 88.62 | 77.33 | 70.73 | Upgrade |
Other Amortization | 9.01 | 9.01 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 1.37 | Upgrade |
Other Operating Activities | -47.87 | -47.87 | -26.01 | 33.39 | 25.52 | 40.64 | Upgrade |
Change in Accounts Receivable | -4.2 | 21.8 | -4.45 | -6.6 | -9.85 | -13.82 | Upgrade |
Change in Inventory | -31.32 | 17.68 | -37.32 | -37.46 | -55.74 | -3.61 | Upgrade |
Change in Accounts Payable | 24.25 | -13.75 | -18.34 | -5.28 | 28.87 | 29.85 | Upgrade |
Change in Other Net Operating Assets | 16.72 | 13.72 | 22.32 | -10.91 | -11.81 | 41.92 | Upgrade |
Operating Cash Flow | 114.19 | 144.19 | 19.71 | 113.82 | 151.56 | 247.01 | Upgrade |
Operating Cash Flow Growth | 76.46% | 631.51% | -82.68% | -24.90% | -38.64% | 479.20% | Upgrade |
Capital Expenditures | -24.16 | -20.16 | -27.41 | -35.37 | -34.92 | -30.86 | Upgrade |
Cash Acquisitions | - | - | - | -152.95 | - | - | Upgrade |
Investing Cash Flow | -24.16 | -20.16 | -27.41 | -188.32 | -34.92 | -30.86 | Upgrade |
Long-Term Debt Issued | - | - | 7.73 | 190 | - | 205 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -20 | - | Upgrade |
Long-Term Debt Repaid | - | -93.16 | -63.42 | -102.05 | -59.04 | -288.41 | Upgrade |
Total Debt Repaid | -5.16 | -93.16 | -63.42 | -102.05 | -79.04 | -288.41 | Upgrade |
Net Debt Issued (Repaid) | -5.16 | -93.16 | -55.69 | 87.95 | -79.04 | -83.41 | Upgrade |
Issuance of Common Stock | 28.84 | 174.84 | 116.82 | - | - | - | Upgrade |
Common Dividends Paid | - | - | -10.79 | -60 | -50 | - | Upgrade |
Other Financing Activities | -75 | -75 | -36.8 | -26.97 | -5.24 | -39.55 | Upgrade |
Financing Cash Flow | -51.33 | 6.68 | 13.54 | 0.98 | -134.28 | -122.96 | Upgrade |
Miscellaneous Cash Flow Adjustments | -1 | 0 | - | - | 0 | - | Upgrade |
Net Cash Flow | 37.71 | 130.71 | 5.84 | -73.52 | -17.64 | 93.19 | Upgrade |
Free Cash Flow | 90.03 | 124.03 | -7.7 | 78.46 | 116.64 | 216.15 | Upgrade |
Free Cash Flow Growth | 94.44% | - | - | -32.73% | -46.04% | - | Upgrade |
Free Cash Flow Margin | 5.38% | 7.62% | -0.48% | 4.83% | 7.85% | 16.43% | Upgrade |
Free Cash Flow Per Share | 1.91 | 2.69 | -0.32 | 3.63 | 5.63 | 10.43 | Upgrade |
Cash Interest Paid | 42.22 | 44.22 | 56.04 | - | - | 9.88 | Upgrade |
Cash Income Tax Paid | 6.18 | 6.18 | 21.87 | 28.41 | 26.52 | 7.99 | Upgrade |
Levered Free Cash Flow | 101.25 | 130.02 | 8.95 | 21.85 | 73.23 | 181.35 | Upgrade |
Unlevered Free Cash Flow | 130.13 | 157.66 | 37.8 | 44.48 | 86.22 | 196.4 | Upgrade |
Change in Net Working Capital | -11 | -42.4 | 55.15 | 79.76 | 46.77 | -73.15 | Upgrade |
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.